BMC Medicine (Apr 2022)

Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification

  • Peh Joo Ho,
  • Weang Kee Ho,
  • Alexis J. Khng,
  • Yen Shing Yeoh,
  • Benita Kiat-Tee Tan,
  • Ern Yu Tan,
  • Geok Hoon Lim,
  • Su-Ming Tan,
  • Veronique Kiak Mien Tan,
  • Cheng-Har Yip,
  • Nur-Aishah Mohd-Taib,
  • Fuh Yong Wong,
  • Elaine Hsuen Lim,
  • Joanne Ngeow,
  • Wen Yee Chay,
  • Lester Chee Hao Leong,
  • Wei Sean Yong,
  • Chin Mui Seah,
  • Siau Wei Tang,
  • Celene Wei Qi Ng,
  • Zhiyan Yan,
  • Jung Ah Lee,
  • Kartini Rahmat,
  • Tania Islam,
  • Tiara Hassan,
  • Mei-Chee Tai,
  • Chiea Chuen Khor,
  • Jian-Min Yuan,
  • Woon-Puay Koh,
  • Xueling Sim,
  • Alison M. Dunning,
  • Manjeet K. Bolla,
  • Antonis C. Antoniou,
  • Soo-Hwang Teo,
  • Jingmei Li,
  • Mikael Hartman

DOI
https://doi.org/10.1186/s12916-022-02334-z
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Family history, and genetic and non-genetic risk factors can stratify women according to their individual risk of developing breast cancer. The extent of overlap between these risk predictors is not clear. Methods In this case-only analysis involving 7600 Asian breast cancer patients diagnosed between age 30 and 75 years, we examined identification of high-risk patients based on positive family history, the Gail model 5-year absolute risk [5yAR] above 1.3%, breast cancer predisposition genes (protein-truncating variants [PTV] in ATM, BRCA1, BRCA2, CHEK2, PALB2, BARD1, RAD51C, RAD51D, or TP53), and polygenic risk score (PRS) 5yAR above 1.3%. Results Correlation between 5yAR (at age of diagnosis) predicted by PRS and the Gail model was low (r=0.27). Fifty-three percent of breast cancer patients (n=4041) were considered high risk by one or more classification criteria. Positive family history, PTV carriership, PRS, or the Gail model identified 1247 (16%), 385 (5%), 2774 (36%), and 1592 (21%) patients who were considered at high risk, respectively. In a subset of 3227 women aged below 50 years, the four models studied identified 470 (15%), 213 (7%), 769 (24%), and 325 (10%) unique patients who were considered at high risk, respectively. For younger women, PRS and PTVs together identified 745 (59% of 1276) high-risk individuals who were not identified by the Gail model or family history. Conclusions Family history and genetic and non-genetic risk stratification tools have the potential to complement one another to identify women at high risk.

Keywords